Sloan DJ, Parris V. Cryptococcal meningitis: epidemiology and therapeutic options. Clin Epidemiol. 2014;6:169–82.
Article
PubMed
PubMed Central
Google Scholar
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525–30.
Article
PubMed
Google Scholar
Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genet Biol. 2015;78:7–15.
Article
PubMed
Google Scholar
Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement system part II: role in immunity. Front Immunol. 2015;6:257.
PubMed
PubMed Central
Google Scholar
Rupprecht TA, Angele B, Klein M, Heesemann J, Pfister HW, Botto M, et al. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol. 2007;178(3):1861–9.
Article
CAS
PubMed
Google Scholar
Mook-Kanamori BB, Brouwer MC, Geldhoff M, Ende A, van de Beek D. Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis. J Infect. 2014;68(6):542–7.
Article
PubMed
Google Scholar
Woehrl B, Brouwer MC, Murr C, Heckenberg SG, Baas F, Pfister HW, et al. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest. 2011;121(10):3943–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goonetilleke UR, Scarborough M, Ward SA, Hussain S, Kadioglu A, Gordon SB. Death is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis. MBio. 2012;3(2):e00272–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Munshi MA, Rella A, Poeta MD. Fungal Infection of the CNS. In: García-Moncó JC, editor. London: CNS Infections; 2014. p.119–37.
Voelz K, May RC. Cryptococcal interactions with the host immune system. Eukaryot Cell. 2010;9(6):835–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rhodes JC, Wicker LS, Urba WJ. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun. 1980;29(2):494–9.
CAS
PubMed
PubMed Central
Google Scholar
Diamond RD, May JE, Kane M, Frank MM, Bennett JE. The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proc Soc Exp Biol Med. 1973;144(1):312–5.
Article
CAS
PubMed
Google Scholar
Rhodes JC. Contribution of complement component C5 to the pathogenesis of experimental murine cryptococcosis. Sabouraudia. 1985;23(3):225–34.
Article
CAS
PubMed
Google Scholar
Macher AM, Bennett JE, Gadek JE, Frank MM. Complement depletion in cryptococcal sepsis. J Immunol. 1978;120(5):1686–90.
CAS
PubMed
Google Scholar
Truelsen K, Young T, Kozel TR. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans. Infect Immun. 1992;60(9):3937–9.
CAS
PubMed
PubMed Central
Google Scholar
Diamond RD, May JE, Kane MA, Frank MM, Bennett JE. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol. 1974;112(6):2260–70.
CAS
PubMed
Google Scholar
Sun D, Zhang M, Liu G, Wu H, Zhu X, Zhou H, et al. Real-time imaging of interactions of neutrophils with Cryptococcus neoformans demonstrates a crucial role of complement C5a-C5aR signaling. Infect Immun. 2015;84(1):216–29.
Article
PubMed
PubMed Central
Google Scholar
Kozel TR, Highison B, Stratton CJ. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect Immun. 1984;43(2):574–9.
CAS
PubMed
PubMed Central
Google Scholar
Kelly RM, Chen J, Yauch LE, Levitz SM. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun. 2005;73(1):592–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ou XT, Wu JQ, Zhu LP, Guan M, Xu B, Hu XP, et al. Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients. J Infect Dis. 2011;203(11):1686–91.
Article
CAS
PubMed
Google Scholar
Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50(3):291–322.
Article
PubMed
Google Scholar
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–21.
Article
PubMed
PubMed Central
Google Scholar
Decken K, Köhler G, Palmer-Lehmann K, Wunderlin A, Mattner F, Magram J, et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun. 1998;66(10):4994–5000.
CAS
PubMed
PubMed Central
Google Scholar
Li Q, Li YX, Douthitt K, Stahl GL, Thurman JM, Tong HH. Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice. Microbes Infect. 2012;14(14):1308–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, et al. Emerging and novel functions of complement protein C1q. Front Immunol. 2015;6:317.
Article
PubMed
PubMed Central
Google Scholar
Fraser DA, Laust AK, Nelson EL, Tenner AJ. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J Immunol. 2009;183(10):6175–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Davson H, Oldendorf WH. Symposium on membrane transport. Transport in the central nervous system. Proc R Soc Med. 1967;60(4):326–9.
CAS
PubMed
PubMed Central
Google Scholar
Alawieh A, Elvington A, Tomlinson S. Complement in the homeostatic and ischemic brain. Front Immunol. 2015;6:417.
Article
PubMed
PubMed Central
Google Scholar
Lévi-Strauss M, Mallat M. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol. 1987;139(7):2361–6.
PubMed
Google Scholar
Gasque P, Fontaine M, Morgan BP. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol. 1995;154(9):4726–33.
CAS
PubMed
Google Scholar
Charchaflieh J, Wei J, Labaze G, Hou YJ, Babarsh B, Stutz H, et al. The role of complement system in septic shock. Clin Dev Immunol. 2012;2012:407324.
Article
PubMed
PubMed Central
Google Scholar
Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun. 2001;69(10):6445–55.
Article
CAS
PubMed
PubMed Central
Google Scholar